Resveratrol, ciglitazone and troglitazone were found to induce E3 ubiquitin ligases in triple-negative breast cancer cells with β-TrCP expression, thereby decreasing PD-L1 protein expression in cancer cells[16]. The gene discussed is BTRC; the disease is cancer.